Health Condition 1: null- ASA grade I â?? II, who are scheduled for diagnostic or therapeutic knee arthroscopic surgery for pain in knee joints/meniscal/ligament repair under Subarachnoid Block.
Conditions
Interventions
Intervention1: Bupivacaine and Morphine: They will be randomly divided into three groups of twenty each. Group A:Will receive 20 ml of 0.25 % Bupivacaine with 1 mg of morphine intra-articularly at en
Sponsors
All India Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Patients of either sex, between age 18 years â?? 60 years, ASA grade I â?? II, who are scheduled for diagnostic or therapeutic knee arthroscopic surgery under Subarachnoid Block and are willing and able to give informed consent will be recruited to the trial.
Exclusion criteria
Exclusion criteria: ASA Grade III â?? IV Patients in whom articular drain is left in situ. Patients in whom Combined Spinal Epidural Analgesia-CSEA was used and epidural catheter is left in situ. Patients with any contra indication to spinal anesthesia. 5. Patients with any contra indication to Bupivacaine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative analgesia and Duration of analgesia.Timepoint: 1year | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative analgesia and Duration of analgesia.Timepoint: 1 year | — |
Countries
India
Contacts
Public ContactDr Babita Gupta
All India Institute of medical sciences, New Delhi
Outcome results
None listed